We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.4B
AUM Growth
+$1.36B
Cap. Flow
+$273M
Cap. Flow %
1.9%
Top 10 Hldgs %
37.21%
Holding
1,342
New
30
Increased
738
Reduced
241
Closed
27

Sector Composition

Rank Sector Weight
1 Real Estate 55.05%
2 Technology 11.48%
3 Consumer Discretionary 4.63%
4 Healthcare 4.39%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSN
1201
DELISTED
Mersana Therapeutics
MRSN
$2K ﹤0.01%
16
NVAX icon
1202
Novavax
NVAX
$1.21B
$2K ﹤0.01%
291
RAPT
1203
DELISTED
RAPT Therapeutics
RAPT
$2K ﹤0.01%
13
SIGA icon
1204
SIGA Technologies
SIGA
$240M
$2K ﹤0.01%
270
SPRY icon
1205
ARS Pharmaceuticals
SPRY
$574M
$2K ﹤0.01%
+367
New +$2.82K
SRRK icon
1206
Scholar Rock
SRRK
$5.89B
$2K ﹤0.01%
208
TBPH icon
1207
Theravance Biopharma
TBPH
$874M
$2K ﹤0.01%
215
TERN
1208
DELISTED
Terns Pharmaceuticals
TERN
$2K ﹤0.01%
151
TSVT
1209
DELISTED
2seventy bio
TSVT
$2K ﹤0.01%
152
WVE icon
1210
Wave Life Sciences
WVE
$1.12B
$2K ﹤0.01%
349
ME
1211
DELISTED
23andMe Holding Co
ME
$2K ﹤0.01%
+48
New +$2.32K
NSTG
1212
DELISTED
NanoString Technologies, Inc.
NSTG
$2K ﹤0.01%
156
ICPT
1213
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
167
ABOS icon
1214
Acumen Pharmaceuticals
ABOS
$154M
$1K ﹤0.01%
165
ABUS icon
1215
Arbutus Biopharma
ABUS
$853M
$1K ﹤0.01%
395
ACET icon
1216
Adicet Bio
ACET
$77.3M
$1K ﹤0.01%
7
ADAP
1217
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
469
ALT icon
1218
Altimmune
ALT
$580M
$1K ﹤0.01%
136
ALXO icon
1219
ALX Oncology
ALXO
$262M
$1K ﹤0.01%
138
ANNX icon
1220
Annexon
ANNX
$811M
$1K ﹤0.01%
131
ATAI icon
1221
AtaiBeckley Inc
ATAI
$2.65B
$1K ﹤0.01%
468
AVIR icon
1222
Atea Pharmaceuticals
AVIR
$367M
$1K ﹤0.01%
242
CDXS icon
1223
Codexis
CDXS
$161M
$1K ﹤0.01%
189
CGEM icon
1224
Cullinan Oncology
CGEM
$1.07B
$1K ﹤0.01%
127
CMPS
1225
Compass Pathways
CMPS
$1.48B
$1K ﹤0.01%
64

Similar funds

Daiwa Securities Group's Q1 2023 Portfolio in Review

As of Q1 2023, Daiwa Securities Group held 1,342 positions worth $14.4B, up 10% from $13B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.2%. Daiwa Securities Group opened 30 new positions and exited 27, leaving the 1,342-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 55% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2023 buy was Global X Aging Population ETF: 800,000 shares worth $21.4M.
  • Daiwa Securities Group added most to VICI Properties in Q1 2023, an estimated $79.2M increase.
  • Daiwa Securities Group's biggest Q1 2023 reduction was Lamar Advertising Co, cutting an estimated $81.1M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $15.2M.
  • Daiwa Securities Group's ten largest holdings make up 37% of its $14.4B portfolio in Q1 2023.
  • Daiwa Securities Group opened 30 new positions and closed 27 in Q1 2023.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2023, filed 2 May 2023.